Although the mechanisms are not yet fully understood, these examples highlight the important role of syndecans in tumor progression and suggest that they are relevant and promising therapeutic targets (Ramani et al., 2013; Barbouri et al., 2014; Theocharis et al., 2015). This evidence concerns the gene SDC1 and neoplasm.